We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

ACCURAY

Accuray is a radiation oncology company that develops, manufactures and sells tumor treatment solutions. Its solution... read more Featured Products: More products

Download Mobile App




TomoTherapy Systems Used to Treat First Patients in Algeria

By MedImaging International staff writers
Posted on 18 Apr 2017
Image: The TomoTherapy system for precision radiation therapy treatment of cancer patients (Photo courtesy of Accuray).
Image: The TomoTherapy system for precision radiation therapy treatment of cancer patients (Photo courtesy of Accuray).
Two TomoTherapy systems installed in Algeria, the first systems in the Africa continent, have begun treating cancer patients.

The advanced radiation treatments that can provide extremely precise treatments for a wide range of cancers are installed in a new radiotherapy and medical oncology center in Sidi Abdellah, in Algeria.

Accuray installed the TomoTherapy Systems at the Radiotherapy and Medical Oncology Center (Sidi Abdellah, Algiers, Algeria). The center has also purchased a third TomoTherapy System, and an Accuray CyberKnife M6 System that will be installed by the end of 2018.

The TomoTherapy System is based on a Computed Tomography (CT) platform and can provide accurate 360-degrees radiation delivery, or use clinician-specified beam angles, and daily 3D image guidance. The system provides standard radiation therapy for breast, prostate, head and neck, and lung cancers, as well as total marrow irradiation.

Corporate SVP and President of Worldwide Commercial Operations at Accuray, Lionel Hadjadjeba, MD, said, "We are honored that the Radiotherapy and Medical Oncology Center team has selected the Accuray systems to expand their cancer treatment options. Their decision reinforces growing global recognition of the importance of radiation therapy in treating cancer. The TomoTherapy and CyberKnife Systems provide an optimal combination of efficacy and safety while minimizing the impact of treatment on daily lives, and will enable the clinical team to confidently provide each cancer patient with a treatment program that addresses his or her individual needs."

MRI System
nanoScan MRI 3T/7T
Digital Radiographic System
OMNERA 300M
X-ray Diagnostic System
FDX Visionary-A
High-Precision QA Tool
DEXA Phantom

Channels

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.